Company Overview

Development Stage

About the Company

[Summary] 天然药物及中药研发企业

苏州玉森新药开发有限公司由上海市学科带头人、苏州工业园区首届人才玄振玉创办的一家专注于筛选和研制天然药物、中药中抗感染、心脑血管领域创新药物、高端仿制药及其产业化的高新技术企业。玉森新药立足科技创新,努力打造国内中药新药研发品牌。位于国内的医药产业集聚地:苏州工业园区生物纳米科技园。

企业平台(Enterprise Platform)
工程中心:3000平方米的标准专业中药新药研究实验室,取得了“苏州市中药分离纯化与制剂工程中心”认证。
分析检测中心:2012年通过中国合格评定国家认可委员会(CNAS)的实验室认可,2015年通过复审。
GMP中试车间:通过新版 GMP认证的固体制剂中试车间。
产业化平台:园区首届扎根计划项目—全资子公司苏州吴淞江制药有限公司,拥有全自动监控的提取车间、现代化固体及液体GMP车间。占地19亩,包括中药分离纯化、口服固体、液体、外用制剂的GMP车间。
销售平台:通过新版 GSP认证的全资子公司——泰州新思维药业有限公司。
知识产权平台:拥有浦东中药知识产权与成果转化平台的全资子公司——上海玉森新药开发有限公司。

技术成果(Technological achievements)
已累计获得临床批文16项,新药证书3项;

国内发明专利已获授权32项,申请PCT专利3项;

共承担国家重大新药创制3项。参与3项,承担国家科技部中小企业创新2项

在研新药项目12项,已产业化项目1项,近三年产业化项目5项。


我们精英汇聚、充满活力,横跨科技研发、药品生产与营销等领域。
我们拥有遍布全国的专业销售网络;
我们拥有全面的网络自动化erp管理手段;
我们拥有科学的人力资源管理和高效的分配激励机制;
我们为您提供优厚的收入和全面的福利;
我们为您提供一个充满培养、激励和激情的工作环境,与企业共同成长 ;
我们为您提供一个可以充分施展您的才华、智慧与抱负的事业舞台;

玉森新药虚位以待,诚聘英才!
公司网站:

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

玉森新药 Financing History (5 rounds)

Manage
股权融资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 见素资本,建安集团

玉森新药 How Fast Is Hiring Growing? (35 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 43%
  • 2024: Down 11%
  • 2023: Up 800%
  • 2022: Down 67%
玉森新药 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
玉森新药 Campus Recruitment & Advanced Degree Talent Demand
Part-time 1 Master's 13
Note: How fast is hiring at 苏州玉森新药开发有限公司 growing? 玉森新药2025: 32 openings (down 43%), 2024: 56 openings (down 11%), 2023: 63 openings (up 800%), 2022: 7 openings (down 67%), 2021: 21 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

玉森新药 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 300%
  • 2024: Down 60%
玉森新药 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 苏州玉森新药开发有限公司 growing? 玉森新药Master's recruitment over the years: 2025: 8 openings (up 300%), 2024: 2 openings (down 60%), 2023: 5 openings, 2021: 1 openings.

玉森新药 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
玉森新药 Doctoral Hiring by Year: 2024 — same as 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 苏州玉森新药开发有限公司 growing? 玉森新药Doctorate recruitment over the years: 2024: 2 openings (down 60%), 2023: 2 openings.

玉森新药 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 苏州玉森新药开发有限公司? Based on an analysis of 玉森新药's job postings over the past year, "医疗卫生/美容保健类" demand: 26.3%, "其他(研发和技术类)": 15.8%, "生物/制药/化工/环保类": 15.8%, "科研类": 7.9%, "机械/仪器仪表类": 1.3%, "电气/能源/动力类": 1.3%. For reference only.

玉森新药 — What Are the Salaries Like? (76 records)

Manage
玉森新药 Salary Overview
salary range: 3K - 30K, 46.1% of roles pay ¥8-15K
Note: salary statistics are based on 76 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 苏州玉森新药开发有限公司?玉森新药46.1% of positions earn 8-15K, Undergraduate salary: ¥。医疗卫生/美容保健类 average salary ¥15.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 玉森新药

(More)
Are salaries high at 苏州玉森新药开发有限公司? We provide: 临床,qa,研究员,医学专员,销售,qc,ra,大区经理,系统工程师,车间,操作工,检验,项目经理,bd,商务经理,工程部,工艺员,普工,生产总监,生产技术. Click to view detailed salary analysis by job.

玉森新药 honors, qualifications & industry associations

玉森新药 Related Industry Tags

Job Category

  • 医疗卫生/美容保健类
    26.3% of total 26.3%
  • 工厂生产类
    25% of total 25%
  • 经营管理类
    23.7% of total 23.7%
  • 质量管理类
    18.4% of total 18.4%

Education

  • 本科
    34.2% of total 34.2%
  • 大专
    27.6% of total 27.6%
  • 硕士
    27.6% of total 27.6%
  • 高中
    5.3% of total 5.3%

Experience

  • 不限
    34.2% of total 34.2%
  • 1-3年
    27.6% of total 27.6%
  • 3-5年
    23.7% of total 23.7%
  • 5-10年
    14.5% of total 14.5%
View Detailed Analysis

What does 苏州玉森新药开发有限公司 require? Who is 玉森新药 hiring? 玉森新药 recruitment: 医疗卫生/美容保健类占比最多占26.3%,其次是工厂生产类占25%. What education can get in at 玉森新药? 本科占比最多占34.2%,其次是大专占27.6%. High education required at 玉森新药? 硕士占27.6%. Work experience required at 玉森新药? 不限占比最多占34.2%,其次是1-3年占27.6%. Where are the job locations at 玉森新药? 苏州占比最多占71.1%,其次是上海占15.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 9,495.5336万(元)
Legal Representative: 玄振玉
Date Established:
Credit Code: 91320594668387663T
Registered Address: 苏州工业园区星湖街218号生物纳米园C30楼

Partners & Suppliers

委托临床试验研究 Source
供应商 临床研究
联合实验室合作,进行中药药理学研究 Source
供应商 科研合作
共同开展中药新药研发合作 Source
供应商 科研合作

People who follow 玉森新药 also follow

玉森新药 Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
制药/药业 生物制药 医药中间体 原料药
制药/药业 医药 健康科技 生产
新药研发 药物研发 医药 抗生素
“Providing solutions for personalized treatment and health management”
“Qingfeng people will strive to build Qingfeng into a century-old brand”
“To become an enterprise with value of existence, serving human health ”
医药 药效学研究 生物制品 生物医药
制药/药业 医药 生物医药 新药研发
制药/药业 医药 中药提取 叶酸
“Top 100 Pharmaceutical Enterprises in China”
中药提取 叶酸 制药/药业 医药
“One of the first China Time-honored Brands”
“Continuous innovation, safeguarding health”
生物科技/生物工程 医药 生物医药 CRO

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates